Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Symposium on Signalling Pathways 2014 – Targeting the PI3K/AKT/mTOR Pathway in Cancer

Signalling Pathways 2014
Start date
28 Feb 2014
End date
01 Mar 2014
Sitges, Barcelona, Spain

The second ESMO Symposium on Signalling Pathways in Cancer focused on the PI3K/AKT/mTOR pathway. The programme was designed provide oncology professionals with the latest scientific developments behind molecular pathways in cancer and a personalised approach to cancer treatment.

This unique oncology meeting brings together academic, clinical and industry researchers, practicing and young oncologists – all stakeholders working in different tumour settings but sharing common underlining mechanisms and signalling pathways.

Access the symposium webcasts

meeting resources


Webcasts from Signalling Pathways 2014 are now online and can be accessed by all ESMO members and conference attendees

Programme 1000x250


Find out more about the Symposium programme here

Signalling Pathways 2014

About the Meeting

Information regarding the venue, contact information and the symposium officers

Signalling Pathways 2014


ESMO gratefully acknowledges the valuable contribution of the following organisations in the ESMO Symposium on Signalling Pathways 2014 – Targeting the PI3K/AKT/mTOR Pathway in Cancer

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.